NasdaqGS:ICLRLife Sciences
Why ICON (ICLR) Is Up 5.1% After New AI-Powered Clinical Trial Partnership With Advarra
In March 2026, Advarra announced a definitive partnership with ICON plc to create a ‘research-ready’ connected site network by integrating ICON’s clinical trial solutions with Advarra’s site CTMS, eISF, and eSource systems used by more than 50,000 investigators worldwide.
An important aspect of this collaboration is Advarra’s data and AI platform feeding ICON with operational intelligence to refine protocol design, planning, and site selection, potentially reshaping how complex global...